Citation: | YAN Xing, CHEN Huai-jing, LIU Hui, DUAN Dan, GONG Zhuo. Willingness and influencing factors of HIV pre-exposure prophylaxis for 295 men who have sex with men in Changsha[J]. Chinese Journal of General Practice, 2022, 20(9): 1560-1564. doi: 10.16766/j.cnki.issn.1674-4152.002649 |
[1] |
莫实德. 中国男男性行为者艾滋病高危行为特征研究进展[J]. 安徽预防医学杂志, 2020, 26(1): 42-45. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYF202001012.htm
MO S D. Research progress on the characteristics of HIV/AIDS high-risk behaviors among men who have sex with men in China[J]. Anhui Journal of Preventive Medicine, 2020, 26(1): 42-45. https://www.cnki.com.cn/Article/CJFDTOTAL-AHYF202001012.htm
|
[2] |
杨人贵, 黄竹林, 欧新华. 长沙市2011-2016年艾滋病流行特征[J]. 中国热带医学, 2018, 18(5): 449-451, 455.
YANG R G, HUANG Z L, OU X H. Epidemiological characteristics analyzation of HIV/AIDS cases in Changsha, 2011-2016[J]. China Tropical Medicine, 2018, 18(5): 449-451, 455.
|
[3] |
MAYER K H, MOLINA J M, THOMPSON M A, et al. Emtricitabine and tenofovir alafenamidevs emtricitabine and tenofovir disoproxil fumarate for HIV pre-exposure prophylaxis (DISCOVER): Primary results from a randomised, double-blind, multicentre, active-controlled, phase 3, non-inferiority trial[J]. Lancet, 2020, 396(10246): 239-254. doi: 10.1016/S0140-6736(20)31065-5
|
[4] |
PENG L J, LI P, GILMOUR S, et al. A mathematical model of biomedical interventions for HIV prevention among men who have sex with men in China[J]. BMC Infect Dis, 2018, 18(1): 600. doi: 10.1186/s12879-018-3516-8
|
[5] |
中华医学会感染病学分会艾滋病丙型肝炎学组, 中国疾病预防控制中心. 中国艾滋病诊疗指南(2018版)[J]. 中国艾滋病性病, 2018, 24(12): 1266-1282. https://www.cnki.com.cn/Article/CJFDTOTAL-XFCR201902002.htm
HIV/AIDS Hepatitis C Research Group, Chinese Association of Infectious Diseases, Chinese Center for Disease Control and Prevention. Guidelines for HIV/AIDS Diagnosis and Treatment in China (2018 edition)[J]. Chinese Journal of AIDS & STD, 2018, 24(12): 1266-1282. https://www.cnki.com.cn/Article/CJFDTOTAL-XFCR201902002.htm
|
[6] |
肖璨, 付朝智, 马婧, 等. 开远市200名男男性行为者艾滋病暴露前预防用药使用意愿[J]. 中国艾滋病性病, 2019, 25(7): 741-742. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA201907025.htm
XIAO C, FU C Z, MA J, et al. Intention to use AIDS pre-exposure prophylaxis among 200 men who have sex with men in Kaiyuan City[J]. Chinese Journal of AIDS & STD, 2019, 25(7): 741-742. https://www.cnki.com.cn/Article/CJFDTOTAL-XBYA201907025.htm
|
[7] |
谢棚印, 王夏, 刘普林, 等. 2015年武汉市301名男男性行为人群对HIV暴露前预防用药使用意愿及相关因素[J]. 中华预防医学杂志, 2017, 51(11): 1001-1006. doi: 10.3760/cma.j.issn.0253-9624.2017.11.009
XIE P Y, WANG X, LIU P L, et al. Willingness and influencing factors of using pre-exposure prophylaxis among 301 men have sex with men in Wuhan city, 2015[J]. Chinese Journal of Preventive Medicine, 2017, 51(11): 1001-1006. doi: 10.3760/cma.j.issn.0253-9624.2017.11.009
|
[8] |
石安霞, Don Operario, 张志华, 等. 男男性行为人群HIV暴露前预防需求与使用障碍研究[J]. 中华流行病学杂志, 2020, 41(3): 343-344, 348. doi: 10.3760/cma.j.issn.0254-6450.2020.03.012
YOU A X, Don Operario, ZHANG Z H, et al. Needs of pre-exposure prophylaxis for HIV infection and related barriers among men who have sex with men[J]. Chinese Journal of Epidemiology, 2020, 41(3): 343-344, 348. doi: 10.3760/cma.j.issn.0254-6450.2020.03.012
|
[9] |
肖璨. 云南省两地MSM人群艾滋病暴露前预防用药接受意愿及影响因素研究[D]. 昆明: 昆明医科大学, 2019.
XIAO C. Study on acceptance willingness and influencing factors of AIDS pre-exposure prophylaxis among MSM population in Yunnan Province[D]. Kunming: Kunming Medical University, 2019.
|
[10] |
ZHENG Z W, QIU J L, GU J, et al. Pre-exposure prophylaxis comprehension and the certainty of willingness to use pre-exposure prophylaxis among men who have sex with men in China[J]. Int J STD AIDS, 2019, 30(1): 4-11. doi: 10.1177/0956462418781142
|
[11] |
马奇三, 王正平, 李金亮, 等. 抗艾滋病药物的现状与挑战[J]. 聊城大学学报(自然科学版), 2020, 33(1): 70-78. https://www.cnki.com.cn/Article/CJFDTOTAL-TALK202001013.htm
MA Q S, WANG Z P, LI J L, et al. Anti-aids drugs status quo and challenges[J]. Journal of Liaocheng University (Natural Science Edition), 2020, 33(1): 70-78. https://www.cnki.com.cn/Article/CJFDTOTAL-TALK202001013.htm
|
[12] |
吴联朋, 何贵清, 胡型忠, 等. 温州地区51例AIDS合并播散性马尔尼菲篮状菌病患者临床特征及死亡危险因素分析[J]. 中华全科医学, 2021, 19(8): 1398-1402. doi: 10.16766/j.cnki.issn.1674-4152.002070
WU L P, HE G Q, HU X Z, et al. Analysis of clinical characteristics and risk factors of death in 51 AIDS patients with disseminated Talaromycosis marneffei in Wenzhou[J]. Chinese Journal of General Practice, 2021, 19(8): 1398-1402. doi: 10.16766/j.cnki.issn.1674-4152.002070
|
[13] |
黄朝辉, 张悦, 郭刘闰南, 等. HIV感染孕产妇启动抗病毒治疗情况及影响因素分析[J]. 中华全科医学, 2021, 19(6): 954-958. doi: 10.16766/j.cnki.issn.1674-4152.001959
HUANG C H, ZHANG Y, GUO L R N, et al. Initiation of antiretroviral treatment among HIV-infected pregnant women and associated factors[J]. Chinese Journal of General Practice, 2021, 19(6): 954-958. doi: 10.16766/j.cnki.issn.1674-4152.001959
|
[14] |
KESLER M A, KAUL R, MYERS T, et al. Perceived HIV risk, actual sexual HIV risk and willingness to take pre-exposure prophylaxis among men who have sex with men in Toronto, Canada[J]. Aids Care, 2016, 28(11): 1378-1385.
|
[15] |
PENG L P, CAO W G, GU J, et al. Willingness to use and adhere to HIV pre-exposure prophylaxis (PrEP) among men who have sex with men (MSM) in China[J]. Int J Environ Res Public Health, 2019, 16(14): 2620-2623.
|